King Luther Capital Management Corp owns $91.19 million in UnitedHealth Group Incorporated (NYSE:UNH)

King Luther Capital Management Corp boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 5.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). . The institutional investor owned 179,068 shares of the health care conglomerate’s stock after acquiring an additional 9,477 shares during the quarter. King Luther Capital Management Corp’s holdings in UnitedHealth Group were worth $91,192,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Swedbank AB purchased a new stake in shares of UnitedHealth Group in the first quarter valued at $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in UnitedHealth Group by 107.8% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock valued at $1,141,113,000 after buying an additional 1,196,758 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock worth $1,942,956,000 after buying an additional 880,183 shares during the last quarter. Baillie Gifford & Co. grew its stake in UnitedHealth Group by 1,125.4% in the second quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock valued at $455,281,000 after purchasing an additional 821,050 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado grew its position in UnitedHealth Group by 3,464.9% during the fourth quarter. Public Employees Retirement Association of Colorado now owns 825,311 shares of the healthcare conglomerate’s stock valued at $434,501,000 after acquiring an additional 802,160 shares during the last quarter. 87.86% of the shares are held by hedge funds and other institutional investors.

Insider buying and selling

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC’s website. In other news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC’s website. Also, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. 0.33% of shares are currently held by corporate insiders.

The Wall Street analyst weighs in

UNH has been the subject of several recent research reports. Robert W. Baird upped their target price on shares of UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. JPMorgan Chase & Co. boosted their price objective on shares of UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a report on Thursday, May 30th. Royal Bank of Canada upped their target price on shares of UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. Morgan Stanley boosted their price objective on UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Finally, StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday. One analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $614.17, based on data from MarketBeat.

Check out our latest report on UNH

UnitedHealth Group stock fell 0.6%

Shares of NYSE:UNH opened at $577.10 on Friday. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $607.94. The company has a market cap of $532.91 billion, a PE ratio of 35.28, a P/E/G ratio of 1.64 and a beta of 0.58. The company’s fifty day moving average is $575.84 and its 200 day moving average is $519.83. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88, and a current ratio of 0.88.

UnitedHealth Group (NYSE:UNH – Get Free Report ) last posted its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. In the same quarter last year, the company posted earnings of $6.14 per share. UnitedHealth Group’s quarterly revenue was up 6.4% compared to the same quarter last year. equities research analysts forecast that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group announces dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be issued a dividend of $2.10 per share. This represents a dividend of $8.40 on an annualized basis and a yield of 1.46%. The ex-dividend date is Monday, September 16. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. The UnitedHealthcare segment provides consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses and individuals; health care coverage and health and wellness services for people age 50 and older that address their needs; Medicaid plans, children’s health insurance and health care programs; and health and dental benefits and hospital and clinic services, and health care products and services for state care programs for the economically disadvantaged, medically underserved, and those without funded health care coverage by employer.

Featured stories

Want to see what other hedge funds own UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).

Get daily news and ratings for UnitedHealth Group – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.